Make your own free website on Tripod.com

HPLC Training - Derex Labs

Impurities List
Home | Herbal Projects | Fine Chemcials | Impurities List | Evening HPLC Training | R&D Training | Job Guranteed HPLC& GC Training | Regulatory Affairs Training | SAS Training | IPR Training | ICH-GCP Training | Short term Training Programmes | Jobs | Academic Projects | About HPLC &GC | Training Schedule | Method development Training | Method Validation Training | Latest Pharma news | Services | Contact Us | Seminors

Impurities available with us- Immediate delivery- Derex labs

7) ABACAVIR SULFATE

a) N 6-cyclopropl-9H-purpine-2,6-diamine (0.5587) (98.7%)

b) (1s,4R)-4-[-2-Anuno-6-(cyclopopylamino)-9H-purin-9-yl]-1-(2,5-diamino-6-chloro-4-pyrimidinyloxy)methyl-2-cyclopentene.(o-pyrimidinylabacavir  (0.8126) (92%)

c) (1s,4R)-4-(2 Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride (abacavir penultimate) (usprc09)  (1.9909) (91%)

 8) ACETAZOLAMIDE

a) 2- (ACETYL.AMINO)-1,3,4-THIADIAZOLE (5.5517) (98.8%)

b) 2- (acetyl.amino)-1,3,4-thiadiazole-5-thiol (2.7267) (99.6%)

c) 2-(acetyl amino)-1,3,4-thiadiazole-5 sulfonamide (1.4314) (96.6%)

 9)ADEFOVIR DIPIVOXIL

a) 9-[[[2-hydroxy phospninyl] methoxy] ethyl] adinine. (1.5757) (97%)

b) (pivaloyloxy)methyl.hydrogen (2-(6-amino-9H-purin-9-yl)ethoxy) methyl phospholhate (9.4036) (92.5%)

 

10) AGNI

a) 4-Amino -2-(trifluoromethyl) benzonitrile. (2.3010) (96.5%)

b) 4-Amino -3-(trifluoromethyl)benzonitrile.  (1.8677) (98.0%)

 11) ALFUZOSIN HYDROCHLORIDE

a) N-[3-[(4-Amino-6,7-dimethoxyquinozolin-2-yl](methyl)amino]propyl] formamide (0.1371) (95.3%)

b) N-[3-[(4-Amino-6,7-dimethoxyquinozolin-2-yl](methyl)amino]propyl]furan-2-carboxamide hydrochloride. (0.8545) (96.8%)

c) 2-chloro-6,7-dimethoxyquinazolin-4-amine  (2.5101)  (99%)

d) N-(4-Amino-6,7-dimethoxyquinozolin-2yl)-N-methylpropane-1,3-diamine hydrochloride salt. (0.8712) (89.5%)

 12) AMBRISENTAN (ON ORDER TO BE GIVEN)

a)2-[(2,2 Diphenylvinyl)oxy]-4,6-dimethylpyrimidine. (87%)

b)(R)-2(4,6-Dimethyl-2pyrimidinyloxy)-3-methoxy-3,3diphenyl propanoic acid.  (97.5%)

c)2S-Hydroxy-3-methoxy-3,3-disphenyl propanoic acid. (98.5%)

d)2S-[(4,6-Dimethylpyrimidin-2-yl]-3-methoxy-3,3-diphenyl propanoic acid. (99%)

 13) AMLODIPINE BESYLATE

a)3-Ethyl5-methyl(4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2-(methylcabanoyl)benzoyl]amino]ethyl]methyl]-1,4-dihydropryridine-3,5-dicarboxylate.(EP-B) (2.5327) (96.7%)

b)3-Ethyl5-methyl(4RS)-4-(2-Chlorophenyl)—[[2-(1,3-dioxo-1,3-dihydro-2H-isonido-2-yl)ethoxy]methyl]-6-methyl-1,4dihydropyridine-3,5-dicarboxylate. (EP-A) (2.8027)(97.9%)

c)3-Ethyl5-methyl2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate fumarate.(EP-D)(1.2000) (98.2%)

 14)AMTOLMETIN GUACIL

a)1-Methyl-5-(4-methylbexoyl)-1H-pyrrole-2-acetic acid. (2.5671)(98.8%)

b)N-[[1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acettk]glycine.(3.0904) (92.4%)

 

15) ANASTROZOLE

a)2,2’-[5-(4H-1,2,4-Triazol-4-ylmethyl)-1,3-phenylene]di(2-methylpropiononitrile).(NO QUANTITY)

b) 2,2’-[5-(4H-1,2,4-Triazol-4-ylmethyl)-1,3-phenylene]di(2-methylpropiononitrile)(0.1844) (99%)

c) 2,2’-[5-(4H-1,2,4-Triazol-4-ylmethyl)-1,3-phenylene]di(2-methylpropiononitrile) (2.1684) (96.8%)

d)2,2’-(5-Methyl-1,3-phenylene)do(2-methylprpiononitrile). (1.5489) (97.3%)

e) 2,2’-(5-Methyl-1,3-phenylene)do(2-methylprpiononitrile). (1.8703)(78%)

 17)APREPITANT

a) 5-[2(S)-[1(R)-[3,5-Bis(trifluoromethyl)phenyl] ethoxy]]-3(S)-(4-flurophenyl)morpholin-4-yl-methyl]-3,4-dihydro-2H-1,2,4-triazole-3-one. (0.2428) (85%)

b) Methyl2-[2-((2R,3S)-2-((IR)-1-(3,5-bis(trifluoromethyl)phenyl)ehoxy)-3-(4-fluorophenyl)-4-morpholinyl)-1-iminoethyl]hydrazine carboxlate. (2.0582) (92.3%)

c) (IR)-1-[3,5-Bis(trifluoromethyl)phenyl](2R,3S)-3-(4-Flurophenyl) morpholinyl ether,p-toluene sulfonic acid salt,  (1.0948) (93.2%)

 18) ARBIDOL HYDROCHLORIDE MONOHYDRATE(NO QUANTITY)

a)6,7-Dibromo-4-(dimethylmino-methyl)-5-hydroxy-1methyl-2-(phenylthiomethyl)-1H-Indole-3-carboxilic acid ethl ester hydrochloride.(98%)

b) 6-Bromo-1-methy-2-(phenyl-thiomethyl)-5-hydroxy-1H-Indole3-carbixtkuc acid ethylester.  (99%)

18)ARIPIPRAZOLE

a)7-(4-Bromobutoxy)-1,2,3,4-tetrahydroquinoline-2-one. (1.3488) (98%)

b)1-(2,3-Dichlorophenyl)piperazine hydrochloride. (2.1897) (96.6%)

c)1-[4-[4-(2,3-Dichlorohenyl)piperain-1-yl]butyl]-7-hydroxy-3,4-dihydrocabostyril.(0.6291) (94.3%)

d)6-[4-[(2-Oxo-1,2,3,4-terahydro-7-quinolinyl)oxy]butoxy]-1,2,3,4-tetrahydro-2-quinolinone.  (1.0410) (92%)

e)7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl] butoxy]-3,4-dihydro-2(IH)-quinolinone.-N-oxide (1.4902)  (93.6%)

 19)ATAZANAVIR SULFATE

a)(3S,8R,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazateradecaedioic acid di mehyl ester. (23Mg) (91%)

b) )(3R,8S,9S,12R)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazateradecaedioic acid di mehyl ester. (190Mg) (77.5%)

c) )(3R,8R,9S,12R)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazateradecaedioic acid di mehyl ester. (160Mg) (88.5%)

 20) ATOMOXETINE HYDROCHLORIDE

a)      s(+) N-Methyl-3-(2-methylphenoxy)-3-phenylpropylaminehedrochloride. (0.7430) (99.3%)

b)      Phenyl-N-methyl-N-[3-(-o-tolyoxy)-3-phenylpropy]carbamate. (1.5780) (99.8%)

c)      L(+) Mandelic acid. (2.3130) (99%)

ATORVASTATIN CALCIUM

a) Tert –butyl2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylacarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate.  ((USPRCI)(3.4495) (99.4%)

21)ATOVAQUONE RELATED COMPOUND

a)      2-[Cis-4-(4-chlorophenyl)cyclohexyl]-3-hedroxy-1,4-naphthalene dione. (1.7529)(94.0%)

b)      4-(4-Chlorophenyl)-cyclohexanecarboxylic acid. (3.000) (96.0%)

c)      2-Chloro-3-[4-(4-chlorophenyl)cyclohexyl]-[1,4]naphthaquinone. (4.0326)(96.0%)

 

22)BENDAMUSTINE HYDROCHLORIDE

a)      1H-benzimidazole-1-methyl-5-N,N-di(2-chloro ethyl)-2-butanoic acid ethyl ester. (1.2481)(96.5%)

b)      4-(7,8-dihydro-6-(2-Chloroethylamino)-3-methyl-1,4-thiazino[3,2-g]benzimidazoly(2)butyric acid. (100Mg) (98%)

23)BICALUTAMIDE RELATED COMPOUND

a)      N-[4-Cyano-2-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide. (2.5084)(99.4%)

b)      N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide. (0.2421)(99.8%)

c)      N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-Acetyloxy-2-methyl-propanamide.  (1.8451) (92%)

d)      4-Fluorobenzene sulphonic acid. (4.8555)(99.6%)

 e)      2,3-Epoxy-2-mehyl-N-[4-Cyano-3-(trifluoromethyl)phenyl]propanamide.(2.8860) (99%)

f)       N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(phenyl)sulfonyl]-2-hydroxy-2-methylpropanamide (1.3540) (98.7%)

g)      N-[4-Cyano-3-(trifluoromehtyl)phenyl]-3-[(4-fluorophenyl)thio]-2-hydroxy-2-methylpropanamide. (0.9850) (99.8%)

h)      N-[4-Cyano-3-(trifluoromehyl)phenyl]-3-[(3-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide. (1.0788) (98.7%)

i)        N-[4-Cyano-3-(trifluoromehyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide. (5.1696) (94.5%)

j)        N-[4-Cyano-3-(trifuoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-methylpropanamide. (.3307)(98%)

24)BORTEZOMIB

a)      N-((S)-1-carbamoyl-2-phenylethyl)pyrazine-2-carboxamide. (0.2469) (99.7%)

b)      N-(Pyrazine-2-ylcarbonyl)-L-Phenylalanine. (1.4289) (99.8%)

c)      [(1(R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]a,omp]butyl]boronicacid. (0.1416) (99.6%)

d)      N(S)-(1-(1(R)-hydrocy-3-methylbutylamino)1-oxo-3-phenyl propane-2-yl)pyrazine-2-carboxamide.(BTBRC04)(0.2866) (98.3%)

e)      N(S)-(1-(1(S)-hydroxy-3-methyl butyl amino)-1-oxo-3-phenylpropane-2-yl)pyrazine-2-carboxamide. (0.1068) (93.4%)

 25)BOSENTAN MONOHYDRATE

a)      4-(1,1-Dimethylethyl)benzenesulfonamide. (3.1283 ) (99.5%)

b)      1,2-bis[[5-(2-mehyoxy-phenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butyl-benzene sulfonamide]ethanediol. (2.3561) (89.8%)

c)      4-(1,1-Dimethylethyl)-N-[6-chloro-5-(2-methoxy-phenoxy)-[2,2’]bipyrimidinyl-4-yl]benzene sulfonamide.(1.0844) (98.5%)

d)      4-(1,1-Dimethylethylethyl)-N-[6-HYDROXY-5-(2--phenoxy)-[2,2’]bipytimidinyl-4-yl]benzene sulfonamide. (1.3575) (96.8%)

  26)CANDESARTAN CILEXETIL

a)      Triphenyl methane  (1.8130) (99%)

b)      Triphenyl methanol  (2.2005) (99.9%)

c)      2-Hydroxy-1-[[2’-(1H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]mehtyl]-1H-Benzimidazole-7-carboxylic acid. (1.2182) (96.5%)

d)      2-hydroxy-1-[[2-‘(1H-Tetrazol-5-yl)[1,1’-biphenyl]-4yl]mehtyl]-1-[[Cyclohexyloxy)carbonyl]oxy)carbonyl]ethyl ester 1H-Benzimidazole-7-carboxylate.  (4.1876) (98%)

e)      Ethyl2-ethoxy-1-[[2’-(1H-tetrazole-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate. (70mg)(93.5%)

f)       2-Ethoxy-1-[[2’-(1H-tetrazole-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-carboxylic acid. (0.9866) (93.4%)

g)      1-(Cyclohexyloxycarbonyloxy)ethyl2-ethoxy-1-[[2’-(N-tryphenylmethyltetrazole-5-yl)biphenyl-4-yl]mehtyl]benzimidazole-7-carboxylate.(2.9285) (95%)

27)CAPECITABINE

a) 5’-Deoxy-5-fluorouridine.(USPRCB)(0.2739) (99%)

b) 2’,3-Di-O-acetyl-5’deoxy-5-fluorocytidine. (10.000) (93.5%)

c) 5’-Deoxy-5-fluoro-N4-(2-Methyl-1-butyloxycarbonyl)cytidine. (0.4000) (93%)

d) 5’Deoxy-5-fluoro-N4-(3-methyl-1-butyloxycarbonyl)cytidine.(0.8000)(88.5%)

g) 5’-Deoxy-5-fluorocytidine.(USPRCA) (6.000) (99.9%)

29) CEFPROZIL

a) (6R,7R)-7-[(R)-2-Amino-2-(p-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid. (0.2540) (98.5%)

b) [R-(Z)][4-Hydroxy-ά-[3-methoxy-1-methyl-3-oxo-1propenyl)amino]]-benzeneacetic acid. (97.5%)

c) 7-Amino-3-(E-propen-1-yl)-3-cephem-4-carboxylic acid. (40mg) (74.2%)

d) 7-Amino-3-(Z-propen-1-yl)-3-cephem-4-carboxylic acid. (300mg) (95.3%)

 30) CELECOXIB

a) 4-[4-(4’-Methylpenyl)-3-(trifluoromethyl)-1H-PYRAZOL-1-yl]-benzensulfonamide. (0.800) (95.5%)

c) 4-[2-hydroxy-5-(4’Methylphenyl)-3-(tri fluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide.( 1.4336) (96.5%)

d) [5-(4-Methylphenyl)-3-tri fluoromethyl-1H-pyrazole].(2.4342) (99.5%)

e) 4-[5-(3’Methylphenyl)-3-(tri fluoromethyl)-1H-Pyrazol-1-yl] benzene sulfonamide.(1.5114)( 94.5%)

32) CINACALCET HYDROCHLORIDE

a) (R)-(+)-1-(1-Naphthyl)ethylamine. (5.2324)(99.9%)

b) (R)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]methyl]-1-napthalenemethane amine hydrochloride. (1.9950) (86%)

c) (αS)- α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyll]-1-napthalenemethanamine hydrochloride. (1.4353) (99.9%)

d)3-(3-(Trifluoromethyl)phenyl)popanal. (7.0805) (96%)

 33) CITALOPRAM HYDROBROMIDE

a) 4-[(4-Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxbutyl]-3-(hydroxbutyl) benxonitrile. (8.8107) (99.5%)

34) CLOPIDOGREL HYDROCHLORIDE

a) [(+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]-pyridine-5(4H)-acetic acid.](3.8000) (99.5%)(USPRCA)

b) [methyl(-)-(R)-(o-chlorophenyl)6,7-dihydrothieno[3,2-c]-pyridine-5(4H)-acetate,hydrogen sulfate].(USPRCC)( 70mg) (98.5%)

 35) CYCLOBENZAPRINE HYDROCHLORIDE

b) 5-(3-Dimehylaminopropyl)-5-hydroxydibenzo[a,e]cyclo heptatriene. (1.0500)(98.5%)

c) 5H-Dibenzo[a,d]cycloheptaten-5-ol. (90mg) (99%)

 36) DARUNAVIR

b) 4-Amino-N-(2R,3S)(3-amino-2-hydroxy-4-phenyl-butyl)-N-isobutyl-benzenesulfonamide. (3.1959) (99.5%)

c) [(1S,2S)-3[[(4-Amino-phenyl-)sulfonyl](2-methylpropyl)amino]-2hydroxy-1-(phenyl-methyl)propyl]carbamic acid (3R,3As,6Ar)-hexahydrofuro[2,3-b]-furan-3-ylester.(0.6000) (74.5%)

37) DESLORATADINE

a)11-[N-Methyl-4-piperidylidene]-8-chloro-6-,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, (7.000) (97.5%)

b) 4-(8-Chloro-5,-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11ylidene)-1-piperidine carboxylic acid ethylester.( 1.9858) (98.5%)

 39)  DIDANOSINE

 a) Inosine. (EP-B) (17.000) (99.5%)

 b) Hypoxanthine.  (EP-A) (5.1782) (99.5%)

 c) 5’-O-Acetyl-2’,3’-dideoxy inosine. (7.8375) (79%)

 d) 9-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)-1,9-dihydro-6H-PURIN-6-one(OR) 2’,3’-Dideoxy-2’,3’-didehydroinosine. (EP-F) (0.2593) (89.8%)

 40) DOCETAXEL TRIHYDRATE

a) Benzenerropanoic acid, β-[[(1,1-dimethylethoxy) carbonyl]amino]-α-hedroxy-(2Ar,4S,4as,6R,9S,11S,12as,12bs,)-12b-(acetyloxy)-12(benzoyloxy)-2a,3,4,4a,5,6,9,11,12,12a,12b-dpdecajudrp-6,11-dojudrpxy-4a,8,13,13-tetramethyl-5-oxo-4-[[2,2-dichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl. (200Mg) (92%)

b)1,7 α-dihydroxy-9,10-dioxo-5 β,20-epoxytax-11-ene-2 α,4,13 α-tetrayl4-acetate2-benzoate13-[(2R,3S)3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate].(10-dehydroxy-10-oxo-7epi-docetaxel) (EP-D) (200Mg) (93%)

c) 1,7 β-dihydroxy-9,10-dioxo-5 β,20-epoxytax-11-ene-2 α,4,13 α-triyl4-acetate2-benzoate13-[(2R,3S)3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate].(10-dehydroxy-10-oxodocetaxel).(EP-B) (350Mg)

d)1,7 α,10 β-Trihydroxy-9-oxo-5 β,20-epoxytax-11-ene-2 α,4,13 α-triyl4-acetate2-benzoate13-[(2R,3S)-3-[[1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate].(7-epi-docetaxel). (EP-C) (250Mg)

 41) DONEPEZIL HYDROCHLORIDE

b) 2,3-Dihydro-5,6-dimethoxy-2-[(4-piperidinyl)methyl]-1H-inden-1 one,Hydrochloride.(2.0000) (97.6%)

c) 1-Benzyl-4-[3-(benzyloxy)-5,6-dimethoxy-1H-2-indenyl],methylpiperidine,Hydrochloride.(2.000) (98.1%)

d) 1-Benzyl-4-[(5,6-dimethoxy-1H-inden-2-yl)methyl]poperidine,hydrochloride.(1.0555) (99.4%)

e) 5,6-Dimethoxy-2-(4-pyridyl)methyl-indan-1-one. (5.6242) (96.7%)

f) 2,3-Dihydro-5,6-dimethoxy-2-(4-piperidinyl)methylinden-1-onehydrochloide. (150Mg) (97.6%)

g) 1-Benzyl-4-[(5,6-dimethoxy-2,3-dihydro-1H-inden-2-YL)methyl]piperdine hydrochloride. (300Mg) (99.1%)

h) 1,1-Dibenzyl-4-[(5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)mehtyl]piperidinium bormide. (3.6544) (97.3%)

 42) DORIPENEM MONOHYDRATE

a) 4-Nitrobenzyl(4R,5S,6S)-6-[(1R)-1-HYDROXYETHL]-4-METHYL-3-[[(3S,5S)-1-(4-nitrobenzyloxycarbonyl)5-(sulfamoylaminomethyl)pyrrolidin-3-yl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carbxylate.(0.8169) (97.5%)

b) 4-Nitrobenzyl(2S,4S)-2-{[aminosulfonyl)amino]methyl]-4-mercaptopyrrolidine-1-carboxylate  (0.3873) (96.5%)

c) 4-Nitrobenzyl(4R,5R,6S)-3-[(diphenoxy)phosphoryl oxy]-6-[(IR)-1-hydroxyethyl]4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate. (2.5708) (98.5%)

 43) DORZOLAMIDE HYDROCHLORIDE

a) (4R,6R)-4-(Ethylamino)-5,6-dihydro-6-mehtyl-4H-THIENO[2,3-b]-thiopyran-2-sulfonamide-7,7-dioxide hydrochloride. (USPRCA) (1.0595) (R,R-isomer-92% )

 (S,S –isomer-8%)

b)(4R,6S)-4-(Ethylamino)-5,6-dihydro-6-mehtyl-4H-THIENO[2,3-b]-thiopyran-2-sulfonamide-7,7-dioxide hydrochloride . (2.1565) (96.5%)

c) (4S,6S)-4-(Acetylamino)-5,6,6-dihydro-6-mehtyl-4H-THIENO[2,3-b]-thiopyran-2-sulfonamide-7,7-dioxide  (4.6660) (88.4%)

 44) DOXAZOSIN MESYLATE

a) N-(2,3-Dihydro-1,4-benxodiaxin-2-yl-carbonyl)piperazine. (7.4780) (99.2%)

b) 4-amino-2-chloro-6,7-dimethoxy quinazoline. (EP-F) (7.2399) (99.5%)

45) DOXYLAMINE SUCCINATE

a) (1RS)-1-phenyl-1-(pyridin-2-yl)ethanol. (9.3589) (100%)

b) N,N-dimethyl-2-[1(RS)-1-phenyl-1-(pyridine-4-yl)ethoxy]ethanamine. (6.1210) (99.4%)

c) phenyl (pyridine-2-yl)methanone(2-benzoylpyridine).(6.2019) (100%)

 46) DULOXETINE HYDROCHLORIDE

a) 1-Naphthol. (3.000) (99.5%)

b) (R,S)-N-Methyl-3-(1-Naphthyloxy)-3-(3-thienyl)propanamine. (50Mg) (97%)

c) (S)-N-Methyl-N-phenyloxy carbonyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine. (2.1200) (99.5%)

d) (R)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propanamine.(0.2900) (99.5%)

DEXPRAMIPEXOLE DIHYDROCHLORIDE

a) N-[(6R)-2-Amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]propanamide. (1.8460) (98.6%)

b) (6R) -4,5,6,7-tetrahydro-1,3-benzothiazol-2,6-diamine. (0.6799) (99.2%)

c) (S)-4,5,6,7-tetrahydro-N-6-PROPYL-2,6-Benxothiaxolediamene dihydrochloride. (0.5122) (100%)

46) EFAVERINZ

a) (S)-6-Chloro-4-pent-1-inyl-4-trifluoro methyl-1,4-dihydrobenzo[d]-1,3-oxazin-one. (3.3991) (99.5%)

b) (S)-6-chloro-4-cylopropyl ethinyl-1-(4-methoxybenzyl)-4-trifluoromethyl-1,4-dihydrobenzo[d]-1,3-oxazin-2-one. (1.4465) (86%)

c) (S)-6-Chloro-4-trifluoromethyl-4-cyclopropylethneyl-1H-benzo[d]-1,3-oxanzin-2-one. (0.2749) (88%)

d) 6-chloro-1-(1S)-camphanoyl-4-4s-(cyclopropylethynyl)-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one. (0.9385) (99.2%)

(e) (S) -5-Chloro-α-(cyclopropylethynyl)-2-amino- α -(trifluoromethyl)-benzine methanol. (1.0545) (98%)

(f) P-Nitrophenol. (4.7965) (99.9%)

g) (4RS)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-Benzoxazin-2-one. (0.7620) (R-Isomer-50.0%)

(S-Isomer-50.0%)

 h) 6-Chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline. (50Mg) (97.5%)

47) ELETRIPTAN HYDROBROMIDE.

a) 3-[[2S)-1-mehyl-2-pyrrolidinyl]mehyl]-2-[2-(phenyl-sulfonyl)ehyl]-1H-indole.(1.0768) (96.5%)

48) EMTRICITABINE

a) 4-Amino-5-fluoro-1-[(2R,5S)-2-(hydroxymehtyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone,S-osxide. (1.0700)(94.5%)

b) (2R,5S)-5-(4-Amino-5-fluoro-2-oxo-2H-PYRIMIDIN-1-YL)-[1,3]OXATHIOLANE-2-CARBOXYLIC ACID(1R,2S, 5R)-methyl ester. (0.3341) (99%)

c) (5S)-5-(4-Amino-5-fluoro-2-oxopyrimidine-1(2H)-yl)-1,3-oxothiolane-2-carboxylic acid. (1.7284) (95.5%)

d) 5-Fluoro-1-(4-(hydroxymethyl)-1,3-oxothiolan-5-yl)pyrimidine-2,4(1H,3H)-dione.

                                                (OR)

2,3’-dideoxy-5-fiuoro-3’-thiouridine(0.1440) (98.5%)

e) 4-Amino-5-fluoro-1-[2-(hydrocymethyl)-1,3-oxathiolan-5-yl]-2(1H)-Pyrimidinone.(0.9676) (-)(cis –Isomer -50..0%

(+)(cis –Isomer -50.0%

50) EPROSARTAN MESYLATE

a) 2-Carbethoxy-3-(2-thienyl)sodiumpropanoate. (10.000) (86%)

d) 4-[[2-butyl-5-formyl-1H-imidazol-1-yl]mehyl]benzoic acid. (0.7540) (98%)

e) 4-((2-butyl-5-((E)-2-carboxyvinyl)-1H-Imidazol-1-yl)mehyl)benzoic acid mesylate.(0.8590) (99.5%)

f) 4-((2-butyl-5-(2,2-dicarboxyvinyl)-1H-imidazol -1-yl)methyl)benzoic acid. (3.7841) (97.5%)

 51) ERLOTINIB HYDROCHLORIDE

a) 6,7-Bis(2-Methoxyethoxy)-N-(3-ethylphenyl)quinazolin-4-amine.(3.4761) (98.5%)

b) 6,7-Bis(2-Methoxyethoxy)-N-(3-ethylphenyl)-N-(2-mehoxyethyl)quinazolin-4-amine. (0.2666) (99.5%)

c) 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline. (60Mg) (98%)

ESCITALOPRAM OXALATE

a) 4-[(4-Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl) benxonitrile.(3.1260) (98.0%)

b) 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile-N-oxide.(1.9206) (96.0%)

 52) ETORICOXIB

a) 2-Chloro-1,3-bis(dimethylamino)trimethinium hezafluoro phosphate (4.7183) (98%)

b) 1-(6-mehyl pyridine-3-yl)-2-[(4-methyl sulphonyl)phenyl]ethanone. (4.1088) (97%)

 53) ETRAVIRINE

a) 4-(6-Amino-5-bromo-2-[4-(aminocarbonyl)anilino]pyrimidin-4-yloxy)-3,5-dimethyl benzamide. (0.5990)(99%)

b) 4-(6-Amino-5-bromo-2-[4-(cyanophenylamino)pyrimidin-4-yloxy) 3,5-dimethyl benzamide. (1.1088) 99.5%)

c) 4-(6-Amino-5-bromo-2-[4 -(cyanophenylamino)pyrimidin-4-yloxy) 3,5-dimethyl benzanitrile.( 0.2300) (95.5%)

d) 4-(2-(4-Cyanoanilino)-6-(4-cyano-2,6-dimethylphenoxy)-4-pyrimidinyl]oxy-3,5-dimethylbenzonitrile. (0.4267) (97%)

e) 4-[5-Bromo-2-(4-cyanoanilino)-6-(4-cyano-2,6-dimethylphenoxy)-4-pyrimidinyl]oxy-3,5-dimethylbenzonitrile. (0.3412)(97.4%)

f) 4-[[6-chloro-5-bromo-2-[(4-cyanophenyl amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile. (0.4357) (99%)

h) 4-(6-chloro-2-(4-cyanophenyl amino) pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile. (0.1600) (98%)

53) EZETIMIBE

a) (3R,4S)-4-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one. (1.6024) (99.3%)

b)(3R,4S)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-(S)-hydroxypopyl]-4-(4-benzyloxyphnyl)-2-azetidinone. (1.7566) (97.6%)

c) (2R,5S)-2-(4-Hydroxybenzyl)-N,5-bis(4-fluorophenyl)-5-hydroxypentanamide.(1.0548) (96%)

d) (3R,4S)-1-(4-fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypopyl]-4-(4-hydroxyphenyl)azetidin-2-one. (1.5020) (97.5%)

 

e) (2R,3R,6S)-N,6-bis(4-fluorophenyl)-tetrahydro-2-(4-hydroxyphenyl)-2H-pyran-3-carboxamide. (0.2738) (96.5%)

 53) FAMCICLOVIR

a) 2-Amino-9(4-hydroxy-3-(hydroxyl methyl)butyl)-3H-purin-6-one. (3.000) (97.5%)

b) 2-[2-(2-Amino-9H-purin-9-yl)ehtyl]-propane-1,3-diol hydrochloride. (0.1976) (93.7%)

c)2-[2-(2-Amino-6-chloro-9H-purin-9-yl)ethyl]-1,3-propane dilo diacetate.(3.1380) (99%)

       d) 4-(2-Amino-9H-Purin-9-yl)-2-(hydroxyl methyl)butyl acetate. (1.6711) (82%)

 e)  2-(Acetoxymethyl)-4-(2-amino-9H-Purin-9-yl)butyl propionate. (0.2555) (99.5%)

 55) FEBUXOSTAT

a) 2-(3-Carbamoyl-4-isobutoxyphenyl)-4-methylthianzole-5-carboxylicacid.(2.2061)(93.3%)

b) Ethyl2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid. (60Mg) (99%)

56) FINASTERIDE

a) (5α,17β)-N-(1,1-dimethyl ethyl)-3-oxo-4-aza androstane-17-carboxamide. (16.000) (98.4%)

b) (5α,17β)-N-(cyclohexyl)-3-oxo-4-aza-5-androst-1-ene-17-carboxamide. (2.900) (93.1%)

c) (5α,17β)-Methyl-3-oxo-4-aza androst-1-ene-17-carboxylate. (50Mg) (98.7%)

d) 1,3-Dicyclohexyl urea.(2.4500) (100%)

 57) FOSINOPRIL SODIUM

a) [(2-Methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl]acetic acid. (7.373) (91.7%)

58) FROVATRIPTAN SUCCINATE

a) (3S)-2,3,4,9-Tetrahydro-3-(methylamiano)-1H-carbazole-6-carboxamide, Succinate. (0.4006) (98.7%) (S-isomer-97.3%)

b) (+)-3-Methyamino-1,2,3,4-Tetrahydro-6-carboxylic acid. (0.9278) (94.8%)

59) FOSAPREPITANT DIMEGLUMINE

a)5-[[(2R,3S)-2-[(IR)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one. (.2260) (99.8%)

b)Benzyl hydrogen3-(((2R,3S)-2((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-ylphosphonate. (0.5100) (99.6%)

FLUVASTATIN SODIUM

a) Methyl()-erthro-E-3,5-dihydroxy-7-[3’(4’-fluorophenyl)-1-(1’methylethyl)-indol-2’-yl]hept-6-enoate. (2.0529)

60) GABAPENTIN

b) Cyclohexane-1,1-diacetic acid. (0.9546)  (99.5%)

d) 2-]1-(Carbamoyl methyl)cyclohenyl]acetic acid. (1.1030) (97.5%)

 62) GEMCITABINE

a) 2’-Deoxy-2’;2’-difluorocytidine.(α-Anomer)  (2.6541) (93.5%)

b) 4-Aminopyrimidin-2(1H)-one. (3.3900) (90%)

 63) GLIMEPIRIDE

a) Methyl[[4-[2-[[(3-ethyl-4-methyl-2-oxo-2,3 dihydro-1H-Pyrrole-1-yl)carbonyl]amino]ethyl]sulphonyl]carbamate. (1.0312) (97.5%)

b) 3-Ethyl-4-mehyl-2-oxo-N-[2-(4-sulphamoylphenyl)ethyl]-2,3-dihydro-1H-Pyrrole-1-carboxamide. (4.2314) (91.5%)

c) 1-[[4-[2-[[(3-ethyl-4-methyl-2-oxo-2,3-dihydro-1H-Pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]3-(cis-4-methylcyclohexyl)urea.(0.1187) (74.4%)

GANCICLOVIR

a) 2-Amino -1H-purin-6(9H)-one. (2.0426) (99.9%)

b) 2-Amino-7-[[2-hydroxy-1-(hydrocymethyl)ethoxy]methyl]-1,7-dihydro-6H-Purin-6-one. (3.1254) (98.9%)

  GEFITINIB

a)      N-(3,5-dichloro-4-fluoro phenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine. (0.4000)

        B)3-chloro-4-fluoro aniline(1.000)

c)7-Methoxy-6-(3-morpholinopropoxy)-3,4-di hydro-4-quinazolinone(1.000)

 64) HYDRALAZINE HYDROCHLORIDE

a) 1-phthalazinone. (3.5000) (99.3%)

b) 2-formylbenzoic acid. (2.4263) (98.9%)

c) 1-clorophthalazine. (2.6678) (96.8%)

 65) IMATINIB MESYLATE

a) N-(2-mehyl-5-aminophenyl)-4-(3-pyridyl)-2-pyrimidine

-amine.(10.000) (97.2%)

b) N-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]phenyl]4-methylbenzamide methanusulfonate.(2.000) (98.7%)

c) Benzoic acid,4-[(4-methyl -1-piperazinyl)methyl]dihydrochlorde.(0.5298) (99.5%)

66) IRBESARTAN

a) Triphenyl methane. (10.8379)

b) Triphenyl mehanol.(0.3360)

 

67)IRBISARTAN

a) 1-pentanoylamino-cyclopentanecarboxylic acid[2’-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amide. (USPRCA)(0.1150) (99.5%)

b) 4-Bromomethyl-2’-cyanobiphenyl.(1.361) (97%)

c) 1-pentanoylamino-cyclpentanecarboxylic acid [2’-(1H-tetrazol-5-yl)biphenyl-4-ylmeythyl]-amide.(USPRACA)(0.6530) (99.5%)

d)2-propyl-3-[[2’(1H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one. (0.5970) (98.9%)

e) 1-[(2’cyanobiphenyl-4-yl)mehyl]-2-N-butyl-4-spirocyclopentane-2-imidazolin-5-one.(1.950) (97.3%)

f) triphenyl methane(10.8379) (99.5%)

g) triphenyl methanol(0.3360)(99.5%)

68) ITRACONAZOLE

a) 4-[4-[4-[4-[[Cis-2-(2,4-dichlorophenyl)-2-(1H-1, 2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]mehyoxy]phenyl]poperazin-1yl]phenyl]-2[[cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmehyl)-1,3-dioxolan-4-yl]methyl]-2,4-dihydro3H-1,2,4-triazol-3-one. (0.3944) (94.1%)

b) 4-[4-[4-[4-Methoxyphenyl)piperazin-1-yl]phenyl]-2-[(IRS)-1-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one. (1.8279) (99%)

c) 2-Butyl-4-[4-[4-[4-[[Cis-2-(2,4-dichlorophenyl)-2(1H-1, 2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]mehoxy]phenyl]peiperaxon-1-yl]phenyl-2-,4-dihydro-3H-1,2,4-triazol-3-one. (1.4654) (99.1%)

d) 4-[4-[4-[4-[[Trans-2-(2,4-dichlorophenyl)-2-(1H-1, 2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]mehyoxy]phenyl]poperazin-1yl]phenyl]-2-[(IRS)-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one. (0.2842) (97.5%)

e) 4-[4-[4-[4-[[Cis-2-(2,4-dichlorophenyl)-2-(1H-1, 2,4-triazol-1-ylmehyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-(1-mehtylethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one. (5.1100) (96.7%)

f) 4-[4-[4-[4-[[Cis-2-(2,4-dichlorophenyl)-2-(1H-1, 2,4-triazol-1-ylmehyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-(1-propyl)-2-,4-dihydro-3H-1,2,4-triazol-3-one. (2.2600) (99.2%)

69) LACOSAMIDE

a) (R)-2-Amino-N-benzyl-3-methoxy propanamide. (1.8636) (97.6%)

b) (2S)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)prapanamide.  (0.1722) (99.1%)

70) LANSOPRAZOLE

a)2-(Chloromethyl-3-methyl-4-(2,2,2-trifluoethoxy)-pyridine. (2.2186) (90%)

b) 1H-Benzimidazole-2-thiol. (3.5000) (99.3%)

e) (2[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfonyl]-benizimidazole).(lansoprazole sulfone)(USPRCA)(2.3077) (94.6%)

f) ) (2[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]thio]-1H-benzimidazole.(USPRCC)(17.000) (98.8%)

 70) LAPATINIB DITOSYLATE MONOHYDRATE

a) N-[3-Chloro-4-[(3-fluorophenyl)mehtyoxy]pehnyl]-6-[5-[[[-2-(mehtylsulphenyl)ethyl]imino]emthyl]-2-furanyl]-4-quinazoliamine.(2.6655) (82.8%)

b) 5-[4-[3-chloro-4-[(3-fluorobenzyloxy)aniline]-6-quinazolinyl]furan-2-carbaldehyde,4-methyl benzenesulphonate. (1.2517) (98.9%)

c) N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((((5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2-yl)mehtyl)(2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine.(2.6655) (90%)

71) LERCANIDIPINE HYDROCHLORIDE

a) 2,6-Dimethyl-5-methyoxy carbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid.(5.2000) (92.1%)

b) 1-[(3,3-Diphenylpropyl)methylamino]-2-methyl-2-propanol.(1.1143) (87.5%)

72) LETROZOLE

a) 4,4-(1H-1,3,4-Triazol-1-ylmethylene)dibenzonitrile.(40Mg) (97.5%)

 73) LEVETIRACETAM

a) (S)-N-(1-Amino-oxobutan-2-yl)-4-chlorobutanamide.(USPRCA)(1.5601) (86.1%)

b) (S)-2-Amino-butanamide hydrochloride.(USPRCB)(2.1245) (95.5%)

c) (S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid.(1.9798) (99.9%)

d) 2-Hydroxy pyridine.(16.021) (99.2%)

 74) LEVETIRACETAM

a)(αS)- α-Ethyl-2-oxo-1-pyrrolidine acetic acid.(2.1588) (99.8%)

b)( αR)- α-Ethyl-2-oxo-1-pyrrolidine acetamide.(1.4392) (99.9%)

c) (R)-(+)- α-Methyl benzylamine.(0.4453) (100%)

 75) LEVOFLOXCIN HEMIHYDRATE

b) (S)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-Pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid.(3.000) (86%)

c) (S)-9-fluoro-3-mehyl-10(piperazine-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid.(Des.Methyl Levoflocacin.)(3.5122) (90%)

d) 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine.(3.6210) (84.5%)

f) 3-mehtyl-10-(4-mehtylpiperazin-1-yl]-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid.(1.7413) (98.5%)

76) LISINOPRIL

a) Trifluoro acetyl L-lysine.(3.8933) (93.6%)

b) (S)-1-Carboxy-3-phenylpropyl-L-lysine.(3.600) (93.6%)

c) 4-Methyl benzene sulphonic acid.(9.5000) (95%)

d) (2S)-1-[(2S)-6-Amino-2-[[(IR)-1-carboxy-3-pehnylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid.(3.0000) (99.6%)

e) (R,S)-2-Amino-4-phenylbutnaoic acid.(1.5100) (99.3%)

LAMIVUDINE

(a)   4-Amino-1-[(2R,3S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pymidin-2(1H)-ONE S-Oxide.

(b)   4-Amino-1-[(2R,3S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pymidin-2(1H)-ONE S-Oxide.(.7000)

77) LOPINAVIR

a) (2S,3S,5S)-2-(2,6-Dimehtylphenoxyacetyl)amino-3-hydroxy-5-triflurormethyl carbonylamino-1,6-dipehylhexane.(0.2660) (99%)

b) (2S,3S,5S)-2-(2,6-Dimehylphenoxyacetyl)amino-3-hydroxy-5- amino 1,6-diphenyl hexane.(9.000) (99%)

c) N-[1-Benzyl-4-[2-(2,6-dimethyl-phenoxy)-acetylamino]-5-pehnyl-pent-3-enylidene]-3-methyl-but-1-enimidic acid.(14Mg) (92.7%)

79) LORNOXICAM

a) 2-Amino pyridine.(3.3940) (99.9%)

b) 6-Chloro-4-hydroxy-2-mehthoxycarbonyl-2H-Thieno[2,3-e]-1,1-dioxide.(2.8890) (99.9%)

 80) LOSARTAN POTASSIUM

a) 4’-[(2-Butyl-4-chloro-5-(hydroxymethyl)-1H-Imidazol-1-yl)methyl]-[1,1’biphenyl]-2-carbonitrile.(0.4400) (99.7%)

b) 4’-[(2-butyl-4-chloro-5-formyl-1H-imidazol-1-yl)methyl]-[1,1’-biphenyl]-2-carbonitrile.(0.1813) (98%)

c) 2-Butyl-4-chloro-1-[[2’-(1H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]-methyl-1H-imidazole-5-carboxylic acid.(0.2164) (95%)

 81) MONTELUKAST SODIUM

b) 2-(1-((((R) -1-(3-(2-(7-Chloroquinolin-2-yl)ethyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)Sulfonyl)methyl)cyclopropyl)acetic acid.(0.6417) (83.2%)

c) 1-[[[(IR)-1-[3-[(IE)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropane acetamide.(0.9128) (96.6%)

e) [1-[[[1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-3-(2-(2-hydroxpropan-2-yl)phenyl]propyl]sulfinyl]methyl]cyclopropyl]acetic acid.(Sulfoxide impurity)(0.2136) (77.6%)

g) 1-[[[(IRS)-1-[3-[(IE)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropane acetic acid.(1.0870) (91%)

h) 2-[2-[3(S)-[3-[2-(7-Chloro-2-quinolinyl)-ethynyl][phenyl]-3-hydroxyprpyl]phenyl]-2-propyanol.(0.3240) (99.1%)

82) MOXIFLOXACIN HYDROCHLORIDE

a) 1-Cyclopropyl-6,8-difluoro-7-[(4aS, 7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride.(EP-A)(1.1568) (98.7%)

b) 1-Cyclopropyl-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid.(EP-B)(3.300) (95.4%)

c) 1-cyclopropyl-8-ethoxy-6-fluoro-7-[(4aS,7aS)-octahydro-6H-Pyrrolo[3,4-b]pyridir-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid.(EP-C)(0.2934) (99.4%)

d) 1-Cyclopropyl -6-fluoro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride.(0.2437) (97.2%)

e) 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-dihydroquinoline-3-carboxylic acid.(2.5049) (96.9%)

f) 1-Cyclopropyl-6-fluoro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihedroquinoline-3-carboxylic acid.(EP-E)(3.1583) (97.4%)

83)NARATRIPTAN HYDROCHLORIDE

a) 2-[3-(1-Methyl-1,2,3,6-tetrahydroppyridine-4-yl)1H-indole-5yl]-ethane sulfonic acid methylamide. (USPRCB)(1.3910) (98%)

b) 3-(1-Methylpiperidin-4-yl)-1H-Indole. (USPRCA)(4.700)(99%)

85) NATEGLINIDE

a) N-(trans-4-ethylcyclohexylcarbonyl)-D-phenylalanine.(0.6524) (82.3%)

b) N-(trans-4-Isopropylcyclohexylcarbonyl)-D-phenylalanine-D-phenylalanine.(0.9769) (92.6%)

c) N-(trans-4-Isopropylcyclohexylcarbonyl)-D-phenylalanine-ethyester.(0.9634) (93.7%)

e) Phenylalanine.(3.0124) (99.9%)

f) Trans-4-isopropylcyclohexylcrboxylic acid.(USPRCA)(.2830) (99..2%)

g) N-(trans-4-isopropylcyclohexylcarbonyl)-L-phenylalanine.(1.0495)(L-90.6%)

h) N-(cis-4-isopropylcyclohexylcarbonyl)-D-Phenylalanene.(USPRCC)(0.1296) (Cis-66%,Trans 29%)

86) NEBIVOLOL HYDROCHLORIDE

a) [2S*[IR*,5S*(S*)]]-alfa,alfa’-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol.(0.4210) (98.7%)

c) [2S*[IR*,5R*(S*)]]-alfa,alfa’-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol].(1.600) (99.9%)

 87) NELFINA VIR MESYLATE

a) 3-Hydroxy-2-methyl benzoic acid.(3.631) (98.9%)

b) 3-Acetyloxy-2-methyl benzoic acid.(2.6252) (98.9%)

c) (3S,4AS,8AS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-amino-4-(phenylthio)butyl]-3-isoquinolinecarboxamide.(1.8420) (96.7%)

d) Benzoic acid.(13.000) (90%)

88) NEVIRAPINE

a) N-(2-Chloro-4-methyl-3-pyridyl)-2-(cyclopropylamino)-3-pyridinecarboxamide.(2.900) (88.3%)

b) [5,11-Dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b;2’,3’-e][1,4]diazepin-6-one].(USPRCA)(1.7321) (97%)

d) 2-((2’-Cyclopropylamino)-3’-pyridyl)-7-methyloxazolo[5,4-B]-pyridine.(0.1097) (99.9%)

e) 11-Propyl-5,11-dihydro-4-methyl-6H-dipyrico[3,2-b;2’3’-e][1,4]diazepin-6-one.(3.900) (99%)

89) NILOTINIB HYDROCHLORIDE

a) 3-(4-methyl-1H-Imidazole-1-yl)-5-(trifluoromethyl)benzenamine.(0.1146) (99.9%)

b) 4-methyl-3-(4-(pyridine-3-yl)pyrimidin-2-yl amino)benzoic acid.(3.3790) (100%)

90) OLANZAPINE

b) 4-Amino-2-methyl-10H-thieno-[2,3-b][1,5]benzodiazapine.(15.3350) (99%)

c) 2-Methyl-4-(1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine.(8.0790) (97.4%)

      d) 2-(1,2-phenylenediamino)-5-methyl-thiophene-3-carbonitrile.(7.2290) (95.9%)

e) 2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-one.(0.6360) (96.7%)

g) 2-Methyl-4-[4-ethyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine.(10.900)(99.6%)

h) 2-(2-Nitroaniline)-5-methyl-thiophene-3-carbonitrile.(11.9380) (98.2%)

i) 2-Amino-5-methyl-thiophene-3-carbonitrile.(7.6560) (99.8%)

91) OLMESARTAN MEDOXOMIL

a) (5-methyl-2-oxo-1,3-dioxol-4-yl)mehtyl4-(2-hydroxy-propan-2-propyl-1-[[2’-(1-triphenylmethyl-1H-tetrazole-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate.(EP-D)(2.7592) (99.4%)

b) Tri phenyl methanol.(3.800) (98.6%)

c) 4-(2-Hydroxypropan-2-yl)-2-propyl-1-[[2’-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl]-1H-Imidazole-5-carboxylic acid.(EP-A)(0.8989) (94.7%)

d) 4-[1-Hydroxy-1-methylethyl]-2-propyl-1-[[2’-[1(triphenylmethyl)-1H-Tetrazol-5-yl]1,1’-biphenyl-4-yl-methyl]-1H-IMIDAZOLE-5-Carboxylicacid(5-methyl-2-oxo-1,3-dioxal-4-yl)methyl ester.(2.3383) (99.5%)

e) 4-[1-Hydroxy-1-methylethyl]-2-propyl-1-[[2’-1H-tetrazole-5-yl]1,1’-biphenyl-4-yl-methyl]-  1H-Imidazole-5-carboxlylic acid.(1.6632) (94.8%)

 92) OMEPRAZOLE MAGNESIUM

a) 5-Methoxy-1H-benzimidazole-2-thiol.(EP-A)(6.988) (99.7%)

b) 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]thio]-1H-benzimidazole.(EP-C)(6.653) (99.1%)

       c) 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]thio]-1H- benzimidazole.(EPD)(0.5736)(94.5%)

d) pyridine,2-(chloromethyl)-3,5-dimethyl-4-methoxy hydrochloride.(8.000) (98.5%)

e) 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridine-2-yl)methyl]sulfinyl]-1H-benzimidazole 1’-oxide.(EP-E)(3.000) (95.5%)

94) OSELTAMIVIR PHOSPHATE

.c) (3R,4R,5S) Methyl4-Acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ececarboxylate. (2.1687) (91.1%)

e) 4-acetylamino-3-hydroxy benzoic acid ethyl ester. (0.2723) (99.2%)

g)(3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylicacid (0.400) (95.4%)

h)Triphenyl phosphine oxide(0.6000) (99.9%)

Ethyl(3R,4R,5S)-4-(Acetylamino)-5-azido-3-(ethylpropoxy)-1-cyclohexene-1-carboxylate(1.400)  (98.9%)

95) PACLITAXILE

a) (2ar,4s,4as,6R,9S,11S,12S,12ar,12bs)-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,6,9,11-tetrahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca(3,4)benz(1,2-b)oxet-5-one.(0.4865)

b) 6,12b-Bis(acetyloxy)12(benzoyloxy)-1,2a3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,9,11-trihydroxy-4a,8,13,13-tetramehtyl-(2ar,4S,4as,6R,9S,11S,12S,12ar,12bs)-rel-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one.(0.1294)

c) (2α,4 α,5β,7β,10 β,13 α)-4-(Acetyloxy)-13{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-ylbenzoate.(0.4595)

d) (2α,4β,5β,7α,10β,13α)-4,10-Bis(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-ylbenzoate.(0.5698)

e) (2as,4s,4as,6R,9S,11S,12S,12ar,12bs)-6-12b-Bis(acetyloxy)-12-(benzyloxy)2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4-[[(2,2-dichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2b]oxet-9-ylester,(ar,βs)-β-(benzoylamino)-α-hydroxy-benzenepropanoic acid.(0.3319)

96) PANTOPRAZOLE SODIUM(PENDING)

a) 5-(difluoromethoxy)-1H-benzimidazole-2-thiol. (EP-C) (200mg)  (99.5%)

b) 2-(chloromethyl)-3,4-dimethoxy-pyridine hydrochloride. (1.500) (99.5%)

c) 5-(difluoromethoxy)-2-[[(3,4-dimethoxypyridin-2-yl)methyl]sulphony]-1H-Benzimidazole. (EP-A)(7.000) (89.6%)

d) 5-(difluoromethoxy)-2-[[(3,4-dimethoxypyridin-2-yl]methyl]sulphanyl]-1H-benzimidazole. (EP-B) (0.4000) (99.5%)

97) PAZOPANIB HYDROCHLORIDE

a) 5-amino-2-methyl benzene sulphonamide.(0.5020) (99.4%)

b) N-(2-Chloropyrimidin-4-yl)N-2,3-trimethyl-2H-indazol-6-amine.(0.6029) (98.7%)

98) PEMETREXED DISODIUM 2.5 HYDRATE

a) N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-D-glutami acid disodium salt.(2.200) (99.5%)

b) N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid.(2.100) (98.7%)

c) N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl]-L-glutamic acid dimetyl ester 4-toluene sulphonic acid salt.(1.300) (99.9%)

 

99) PERINDOPRIL ERBUMINE

a)(2S, 3AS,7AS)-1-[(S)-N-[(S)-1-Carboxybutyl]alanyl]ocathydro-1H-Indole-2-carboxylic acid.(EP-B)(2.3672) (99.9%)

b) (2S,3as, 7as)-octahydro-1H-Indole-2-carboxylic acid.(EP-A)(1.100) (93.7%)

100) PIOGLITAZONE HYDROCHLORIDE

a) 5-[[4-2-(5-Ethyl-2-pyridyl)ethox]phenyl]methyl]-2-imino-thiazolidine-4-one.(1.8150) (94.2%)

b) 5-{4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl}-4-[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenoxy]-2,5-dihydro-1,3-thiazole-2-one.(0.700) (90.5%)

101) PITAVASTATIN CALCIUM

A) (3R,5S,E)-7-(2-Cyclopropyl-4-(4-fluoropehnyl)quinolin-3-yl)-3,5-dihydroxhept-6-enoic acid,calcum salt.(0.4401) (97.8%)

B) (4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-4-hydroxytetrahydro-2H-pyran-2-one.(0.6311) (96.5%)

i) (4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-4-hydroxytetrahydro-2H-pyran-2-one.(0.331) (98%)

j) (3R,5S,E)-teri-butyl-7-(2-cyclopropyl-4-(4-fluorophnyl)quinolin-3-yl)-3,5-dihroxyhept-6-enoate(2.9129)(96%)

102) PRAMIPREXOLE DIHYDROCHLORIDE

a) (S)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole.(0.2498) (99.7%)

b) (S)-2-Amino-6-propionamido tetrahydro benzothiazole.(2.6433) (99.8%)

c) (R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine.(0.3423) (97.7%)

103) PROGUANIL

a) 1-Cyano-3-(1-methylethyl)guanidine.(1.2572) (95.3%)

b) 4-chloroaniline.(1.300) (98.5%)

 105) QUETIPINE HEMIFUMARATE

a) Dibenzo-(1,4)-thiazepine-11(10H)-one.(1.000) (96.4%)

b) 11-(1-piperazinyl)dibenzo-(1,4)-thiazepine.(0.1100) (99.2%)

c) 2-(4-Dibenzo[b,f]-[1,4]-thiazepine-11-yl-1-piperzinyl)ethanol hemifumarate.(26.00) (98.5%)

REPAGLINIDE

a) (3-ethoxy-4-ethoxycarbonyl-phenyl acetic acid).(USPRCB)(EP-B)(2.1177) (99.7%)

b) (S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine,N-acetyl-L-glutamate salt (USPACA)(3.0540) (98.6%)

c) Ethyl2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amono-2-oxoethyl]benzoate.(EP-D)(3.0996) (99.7%)

d) 4-(carboxymethyl)-2-ethyxybenzoic acid.(EP-A)(3.3241) (98.7%)

106) RABEPRAZOLE SODIUM

a) 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]mehtyl]thio]-1H-benzimidazole.(14.500) (99.5%)

c) 4-(3-Methoxypropoxy)-3-methyl-2-chloromethyl-pyridine,hydrochloride.(70.00) (99.8%)

d) 1H-benzimidazole-2-thilo.(35.00) (99.9%)

108) RALTEGRAVIR POTASSIUM

a) N-(4-Fluorobenzyl)-2-(2-aminopropan-2-yl)-1,6-dihydro-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide.(1.6840) (99.9%)

c) N4-(4-Flrorobenzyl)-2-1[(2-hydrazino-2-oxoacetyl)amino]-1-methylethyl-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-4-pyrimidine carboxamide.(5Mg) (87%)

e) 5-Hydroxy-1-merhyl-2-(1-mehyl-1-[(5-methyl[1,3,4]oxadiazol-2-carbonyl)-amino]-ethyl)-6-oxo-1,6-dihydro pyrimidine-4-carbxylica cid benzylamide.(1.1380) (89%)

f) N1-[1-(4-[(4-Fluorobenzyl)amino]carbonyl-5-hydroxy-1mehyl-6-oxo-1.6-dihydro-2-pyrimidinyl)-1-methylethyl]ethanediamide.(1.6388) (79.8%)

109) RAMIPRIL

a) Benzyl(cis,endo)-octahydrocyclopenta[b]pyrrole-2(S)-carboxylate hydrochloride.(0.6020) (82.5%)

b) N-[1(S)-Carboethoxy-3-pehnylypropyl]-(S)-alanine.(2.3065) (98.9%)

c)(2S,3as,6as)-1[(S)-2-[[(S)-1-carboxy-3-phenylpropyl]amino]propanoyl]oxtahydro cyclopenta[b]pyrrole-2-carboxylic acid.(EP-E)(2.9785) (98%)

          111) RASAGILINE HYDRCHLORIDE

       a) (R)-2,3-Dihydro-1H-inden-1-amine hydrochloride.(2.1984) (95.5%)

       b) (IS)-2,3-Dihydro-N-2-propynl-1H-inden-1-amine hydrochloride.(0.1320) (99.4%)

     112) RILUZOLE

        b) Thiourea[4-Triflouromethoxyphenyl].(0.8060) 98.7%)

        c) 4-Bromo-6-(trifluoromethoxy)-2-benzothiazolamine.(0.600) (97%)

    113) RIMONABANT

      a) 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-pyrazole-3-carboxylid  acid. (2.831)                                 (76.5%)

d) 5-(4-chlorophenyl)-1-(2,4-dichlorohenyl)-4-methyl-pyrazole-3-carbuxamide.(3.840) (93.9%)

c) 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-mehtyl-pyrazole-3-carbronylpiperidile(3.840) (91.4%)

 e) N-Piperidino-1-(2,4-dichlorophenyl)-5-phenyl-4-methyl-pyrazole-3-carboxamide.(3.552) (92.2%)

 f) N-Piperidino-5-(3-chlorophenyl)-1-(2,4-dichlorophenyl)-4-mehtyl-pyrazole-3-carboxamide.(3.0567) (99.5%)

 115) ROPINIROLE HYDROCHLORIDE

  a) 4-(2-Dipropylamino-ethyl)-1H-indole-2,3-dione hydrogen chlorode.(.5610) (97.7%)

  b) 2-(2-Oxo-1,3-dihydro-4-indolyl)ethyl-p-toulenesulphonate.(0.767) (94.3%)

  c) Maleic acid.(1.2030) (99.7%)

117) RUFINAMIDE

  a) Ethyl1-[(2,6-Difluorobenzyl)-1h-1,2,3-triazole-4-carboxylate.(1.3867) (99.4%)

  b) 1-[(2,6-Difluorophenyl)-methyl]-1H-1,2,3-triazole-5-carboxamide.(1.404) (93.6%)

118) RITONAVIR

 a) y-(S)-Amino α-(IS)-(thiazolylmethyloxycarbonyl)-amino-(2-phenylethyl)-(S)-benzene butnol.(5.3473) (97.8%)

c) N-[[(methyl[[2-(1-methylethyl)-4-thizoyl]mehtyl]amino]carbonyl]-L-valine.(9.5740) (93%)

      d) (2S)-N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-3-methyl-2-[[methyl[[2-(1-     methylethyl)thiazol-4-yl]mehtyl]carbamoyl]amino]butanoyl]amino]-5-phenylpentyl]-3-mehtyl-2-[[methyl[[2-(1-methylethyl)thiazol-4-yl]mehtyl]carbamoyl]amino]butanamide.(1.2864) (96.7%)

         119) RIZATRIPTAN BENZOATE

           a) N,N-Dimethyl-5-(1H-1,2,4-trizol-1-yl-methyl)-1H-indole-3-ehanamine N-oxide.(0.4306) (93%)

           b) 2-[5-(1H-1,2,4-trizol-1-yl-methyl)-1H-Inidole-3-yl]ethanol.(1.093)(94.5%)

   120) SAQUINAVIR MESILATE

  a) (2R)-N’-[(IS,2R)-1-benzyl-3-[(3S,4as,8as)-3-[(1,1-dimethylethyl)carbamoyl]octa-     hydroixoquinolin-2-(1H)-YL]-2-hydroxypropyl]-2[(quinoin-2-ylcarbonyl)amino]butanediamide.(EP-D)(10Mg) (97%)

  b) Ethyl(2S)-4-Amino-4-oxo-2-[(quinolin-2-ylcarbonyl)amino]butanonoate.(EP-B)(2.1687) (72.8%)

  c) (2S)-4-Amino-4-oxo-2-[(quinolin-2-ylcarbonyl)amino]butanoic acid.(EP-A)(0.2062) (99%)

  d) (3S,4aS,8aS)-2-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(1,1-                   dimethylethyl)decahydroisoquinoline-3-carboxamide.(EP-C)(0.3945) (99.5%)

 

   121) SILDENAFIL CITRATE

  a) 5-{2-Ehoxy-5-[(4-{[4-ehoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-Pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]sulfonyl}piperazino)sulfonyl]phenyl}-1-mehtyl-3-propyl-6,7-dihydro-1H-PYRAZOLO[4,3-D]Pyrimidin-7-one.(2.5030) (99%)

  b) 4-(2-ethoxy benzamido)-1-mehtyl-3n-propyl-pyrazole-5-carboxamide.(0.5141) (99.3%)

  c) 4-{[4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-Pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]sulfonyl}-1-methylhexahydropyrozin-1-ium-1-olate.(0.5062) (93.6%)

  d) 4-Ethoxy benzoic acid.(3.0800) (99.9%)

  e) 2-Ethoxy benzoic acid.(10.000) (87.3%)

  f) 3-Ethoxy benzoic acid.(0.6000) (99.3%)

  g) 4-Ethoxy -3-(6,7-dIhydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzenesulfonic acid.(1.500) (99.5%)

  h) 5-(2-Ethoxy phenyl)-1-methyl-3n-propyl-1,6-dihydro-7H-Pyrazolo[4,3-d]pyrimidine-7-one.(0.1340) (99.2%)

   i) 1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-Pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]piperazine.(60Mg) (82.2%)

   j) 1-Methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide. (7.962) (97.3%)

  k) 5-{2-Ethoxy-5-[(4-methypiperzino)sulfonyl]phenyl}-3-ethyl-1-methyl-6,7-dihydro-1H-PYRAZOLO[4,3-D]pyrimidin-7-one.(1.1083) (99.2%)

      122)  N

         a) (1S,3R,7S,8S,8AR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxotetrahdro-2H-pyran-2-yl]ethyl]-3,7-dimehyl-1,2,3,7,8,8A-hexahydronaptalen-1-yl(2S)-2-Methylbutanoate.(6.00) (99.3%)

   b) (3R,5R)-7-[(1S,2S,6R,8S,8AR)-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8A-Hexahydronapthlen-1-yl]-3,5-dihydroxyheptanoic acid.(0.1790) (97.6%)

123) SOLIFENACIN SUCCINATE

c) 1-phenyl-3,4-dihydro isoquinoline.(3.100) (93%)

g) (IS)-1-Phenyl-1,2,3,4-tetrahydro isoquinoline.(2.500) (99.9%)

SERTRALINE HYDROCHLORIDE

a) (+/-)-Cis-4-phenyl-1,2,3,4-tetrahydro-N-napthalenamine hydrochloride (EP-B) (3.3000) (95.6%)

b) (D) Mandelic acid.(EP-E) (3.00) (99.9%)

c) (+/-)-Cis-4-(chlorophenyl)-1,2,3,4-tetrahydro-N-napthalenamine hydrochloride(EP-C) (70mg) (95.4%)

d) (+/-)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-napthalenone.(EP-F) (1.00) (100%)

e) (+/-)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-napthalenone.oxime(2.3000) (98.5%)

f) (1S,4R)-Trans-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrrochloride.(EP-A) (9.00) (91.5%)

g) (1R,4R)-Cis-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride.(EP-G) (5.000)(87%)

124) STAVUDINE

a) 1-(2-Deoxy-beta-D-ribofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-Dione.(0.5917) (99.5%)

b) 5-Methylpyramidine-2,4-(1H,3H)-Dione.(4.0219) (99.9%)

c)3’,5’-Anhydro thymidine.(11.00) (98.9%

d) 3’,5’-Di-(O-mesyl)-thymidine.(3.200) (90.5%)

b) 5’Benzoyl-2’,3’-didhydro-3’-deoxythymidine.(2.1633) (96%)

126) TADALAFIL

a) (IR,3R)-Mehyl1,2,3,4-tetrahydro-2-chloroacetyl-(3,4-mehylenedioxyphenyl)-9H-Pyrido[3,4-6]indole-3-carboxylate.(1.1582) (99.7%)

b) (6R-12aS)-2,3,6,7,12,12a-Hexahydro-2-mehtyl-6-(3,4-methylenedioxyphenyl)pyrazino[2,1:6]pyrido[3,4-6]indole-1,4-dione.(0.5470)(99.7%)

c) ) (6S-12aS)-2,3,6,7,12,12a-Hexahydro-2-mehtyl-6-(3,4-methylenedioxyphenyl)pyrazilo[2,1:6]pyrido[3,4-6]indole-1,4-dione.(0.5470) (99.7%)

d) (6S-12aR) -2,3,6,7,12,12a-Hexahydro-2-mehtyl-6-(3,4-methylenedioxyphenyl)pyrazilo[2,1:6] pyrid0 [3,4-6] indole -1,4-dione. (2.6000)(99.7%)

127) TELMISARTAN

b) Methyl4’-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole-1-yl]methyl]biphenyl-2-carboxylate.(40Mg) (99.0%)

c) 4-methyl-6-(1-Methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole.(EP-A)(0.2367) (99.59%)

d) 1-[(2’-Carboxybiphenyl-4-yl)methyl]-4-methyl-2-propyl-1H-benzimidazol-6-carboxylic acid.(EP-E)(1.4254) (99.8%)

e)  4’-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxamide.(EP-F)(1.0666) (96.5%)

(f) 4’-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2- carbonitrile. (EP-G)(1.3160) (99.6%)

(g) Methyl4’-(bromo methyl)biphenyl-2-carboxyalte.(1.000) (94%)

(h) 4’[[4-Methyl-6-(1-methyl biphenyl-2-carboxylicacid)-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidaxol-1-yl]methyl]biphenyl-2-carboxlicacid.(1.2716) (99.6%)

 128) TEMOZOLAMIDE

a) 5-Amino-1H-imidazole-4-carboxamide hydrochlororide.(0.5475) (99.9%)

b) 4-Nitro phenol.(1.4631)(100%)

c) 5-Amino-1-(N-Methyl carbamoyl)imidazole-4-carboxamide.(0.1989) (95.3%)

129) TENOFOVIR DISOPROXIL FUMARATE

 g) [[(IR)1-(6-Amino-9H-Purin-9-yl)propan-2-yl oxy]methylphosphonyl]methyl isopropyl carbonate.(2.0136) (86.4%)

h) (R)-[[2-(6-Amino-9H-yl)-1-methylethoxy]methyl]phosphonic acid Isopropoxycarbonyl oxymethyl ester isopropyl ester furmarate.(1.9840) (82%)

l) 9-propenyl adenine.(2.4019) (91%)

m) [[(1S)-2-(6-Amino-9H-purin-9-yl)-1-methyl ethoxy]methyl]phosphonicacid disoproxil fumarate.(0.8155) (89%)

130) TERBINAFINE HYDROCHLORIDE

a) N-methyl-C-(naphthalene-1-yl)methanmine.(EP-A)(0.9100) (96.4%)

b) (2Z)-N-6,6-trimethyl-N-(naphthalene-1-ylmethyl)hept-2-en-4-yn-1-amine.(EP-B)(0.6400) (95.3%)

c) 1-Bromo-6,6-dimethyl hept-2-ene-4-yne.(0.9511) (97%)

131) TIAGABINE HYDROCHLORIDE

b) Bis(3-methyl-2-thieyl)methanone.(6.6282) (97%)

c) R)-Ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidine carboxylate.(5.00) (97%)

d) (S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-butenyl]nipecotic acid.hydrochloride.(5.00) (92%)

132) TOLTERODINE TARTRATE

a)2-[(2S)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol tartaric acid.(17.123) (99%)

b) 2-Methoxy-5-methyl-N,N-bis(1-methylethyl)-gamma-phenylbenzene propanamine.(2.0213) (99%)

133) TOLVAPTAN

a)(4-Amino-2-methylphenyl)(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzo[b]azipin-1-yl)methanone.(0.5450) (99%)

b) 2-Methyl-4-[(2-methylbenzoyl)amino]benzoic acid.(1.8240) (98%)

d) 4-[(5-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine-1-yl)carbonyl]-3-methylphenyl-2-methylvenzamide.(0.4466) (99%)

e) 7-chloro-1-[2-methyl-4-[(2-methylbenzoyl)amino]benzoyl]-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine.(0.5592) (99%)

134) TORSEMIDE

a) 4-(3-methylphenyl)-2H-Pyrido[4,3-e]-1,2,4-thiadiazin-3(4H)one1,1-dioxide.(EP-A(0.2490) (96.5%)

b) [4-[(3-methylphenyl)amino]-3-pyridine sulfonamide](USPRACA)(EP-B)(5.3127) (99.7%)

c) [N-[(n-butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide].(USPRCB)(EP-D)(1.0055) (97.1%)

d) N-[(n-ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide].(USPRCC)(EP-C)(0.6609) (98.5%)

135) TRANDOLAPRIL

a) N-[(IS)-1-(Ethoxycarbonyl)-3-phneylpropyl]-L-alanine.(3.800) (98.7%)

b) Benzyl(2S,3aR,7aS)-octahydroindole-2-carbxylate.(3.3643) (90.5%)

c) (2S,3ar,7as)-1-[(2s)-2-[[(IS)-1-Carboxy-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1H-Indole-2-carboxylic acid.(EP-E)(2.2789) (98.1%)

d) Ethyl(2s)-2-[(3R,5as,9ar)-3-methyl-1,4-dioxoperhydropyrazino[1,2-a]indol-2-yl]-4-phenylbutanoate.(EP-D)(1.5367) (95%)

 136) VALACICLOVIR HYDROCHLORIDE

a) 2-Amino-1,9-dihydro-6H-purin-6-one.(EP-A) (3.5411) (99.9%)

b) 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-Purin-6-one.(EP-B)(5.6425) (99.5%)

c) N,N-Dimethylpyridin-4-amine.( EP-G)(0.6704)(99.9%)

f) 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl]N-methyl-L-valinate.(EP-R)(2.666) (84.3%)

g) 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl]N-methyl-L-alaninate.(EP-H)(2.0587) (92.6%)

i) 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)Methoxy]ethyl N-formyl-L-valinate. (1.0954) (99-6.2%)

137) VALSARTAN

b) N-(1-Oxopentyl)-N-[[2’-(1H-tetrazol-5-yl)[1.1’-biphenyl]-4-yl]methyl]-L-valine benzyl ester.(7.7572) (91.8%)

c) (S)-N-Butyryl-N-[[2’-(1H-tetrazol-5-yl)biphenyl]-4-yl]methyl]-valine.(2.5021) (99.4%)

d) N-(1-Oxepentyl)-N-[[2’-(1H-tetrazol-5-yl)[1.1’-biphenyl]-4-methyl]-D-valine.(2.1107) (90%)

138) VARDENAFIL HYDROCHLORIDE

a) 2(2-ethoxyphenyl)-5-methyl-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-4-one.(3.4645) (99.7%)

b) 2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfinyl]phenyl-5-methyl-7-propylimidazol[5,1-f][1,2,4]triazin-4(3H)-One.(1.0273) (97.2%)

139) VORICONAZOLE

a) (2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol.(1.0081) (82%) (97.5%)

b) (2R,3S)/(2S,3R)-3-(5-Fluoro-6-chloro-pyrimidin-4-yl)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)butane-2-ol.(0.5047) (97.0%)

c) 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone.( 0.4813) (98.1%)

140) VALGANCICLOVIR HYDROCHLORIDE

a) 9-(1,3-Dihydroxy propan-2-yloxy)methyl)-2-amino-1H-purin-6(9H)-one. (USPRACA)(2.7210) (99.7%)

141) ZIDOVUDINE

a) Triphenyl methanol.(ZVDRCA)  (15.000) (100.0%)

b) 5-Methyl pyrimidine-2,4(1H,3H)-dione amine.(3.918)  (99.9%)

142) ZIPRASIDONE

a)6-Chloro-5-(2-chloroethyl)oxindole.(1.8509) (93.4%)

b)1-(1,2-Benzisothiazol-3-yl)piperazine.(3.4295) (98.0%)

143) ZOLMITRIPTAN

b) (S)-4-(4-Amino benzyl)-2-oxazolidinone hydrochloride.(0.2844) (96.0%)

c) (4R)-4-[[3-[2-(Dimethyl amino)-1H-Indol-5yl]methyl]-2-oxazolidinone.(9.9011) (97.4%)

144) ZOLEDRONIC ACID

a) Imidazole(12.900) (99.08%)

b) Ethyl imidazole-1-yl-acetate.(0.2840) (91.0%)

145) ZALTOPROFEN

a)2-(10,11-dihydro-10-oxo  dibenzo[b,f]thiopin-2-yl)propanoic acid methylester. (2.1784) (98.9%)

b) 2-(3-(Carboxymethy)-4-(phenylthio)phenyl)propanic acid.(0.4477) (94.8%)

c) 2-propionyl-10,11-dihydrodibenzo[b,f]thiepin-10-one.(2.0175) ( 99.3%)

146) ZONISAMIDE

a) 1,2-Benzisoxazole-3-methane sulfonic acid sodium salt.(3.066) (99.8%)

b) 1,2-Benzisoxazole-3-acetic acid.(2.5821) (99.9%)

148) ENTACAPONE

a) 2-Cyano-N,N-diethylacetamide.(ETPRCB)(.500)

b) (2E)-2-Cyano-3-(3-methoxy-4-hydroxy-5-nitro phenyl)-N,N-Diethyl-2-propenamide.(ETPRCA)(0.500)

149) FELBAMATE

a) 2-phenyl-1,3-propanediol.(FBTRC02)(2.3888)

 152) ESCITALOPRAM OXALATE

a) 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5- carbonitrile –N-Oxide.(1.9206) (97.59%)

b) 4-[(4-dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxmethyl)benzonitrile.(3.1206) (91.6%)

153) LAMOTRIGINE BENZOIC ACID

a) 2,3-Dichloro benzoic acid.(0.9384)

b) N-[5-Amino-6-(2,3-Dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide..(1.5906)


Latest Pharma news

For details contact : GK Naidu on 8008436436